Qingdao Vland Biotech INC.(603739.SH) obtained a new veterinary drug registration certificate.
Vland Biotech (603739.SH) announced that, upon review by the Ministry of Agriculture and Rural Affairs, the "Swine Streptococcus suis, Glaesserella parasuis, and Porcine Circovirus Type 2 Triple Inactivated Vaccine (Type 2 QH Strain + Type 5 LZ Strain + Cap Protein)" jointly applied for by the company's wholly-owned subsidiary Qingdao Vland Animal Health Group Co., Ltd. and other units has been approved as a Class III new veterinary drug; the "Qingying Granules" jointly applied for by the company and other units has been approved as a Class IV new veterinary drug, and the New Veterinary Drug Registration Certificate was issued in recent days.
Qingdao Vland Biotech INC. (603739.SH) announced that, upon review by the Ministry of Agriculture and Rural Affairs, the "Swine Streptococcus suis, Glaesserella parasuis, and Porcine Circovirus Type 2 Trivalent Inactivated Vaccine (Type 2 QH Strain + Type 5 LZ Strain + Cap Protein)" jointly applied for by the company's wholly-owned subsidiary Qingdao Vland Animal Health Group Co., Ltd. and other entities was approved as a Class III new veterinary drug; the "Qingying Granules" jointly applied for by the company and other entities was approved as a Class IV new veterinary drug, and the New Veterinary Drug Registration Certificate was issued in recent days.
Related Articles
CHINA EAST AIR (00670) August passenger turnover up 6.69% year-on-year.
Foshan Haitian Flavouring and Food (03288) repurchased 732,000 A shares and 548,400 H shares on September 15.
WEIGAO GROUP (01066) repurchased 160,400 shares for approximately HK$507,600 on September 15.
CHINA EAST AIR (00670) August passenger turnover up 6.69% year-on-year.
Foshan Haitian Flavouring and Food (03288) repurchased 732,000 A shares and 548,400 H shares on September 15.
WEIGAO GROUP (01066) repurchased 160,400 shares for approximately HK$507,600 on September 15.
RECOMMEND
